New Enterprise Associates 17, L.P. 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-19 4:05 pm Purchase | 2026-03-17 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,797,030 9.700% | 7,797,030 (New Position) | Filing |